EGFR and nasopharyngeal carcinoma: However, a new generation of EGFRi, AFA, which is an irreversible EGFR/HER2 inhibitor, was found to inhibit cell growth, augment the anticancer effect of gemcitabine [42], and enhance radiosensitivity in NPC [43].